About smith & nephew plc - SNNUF
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
SNNUF At a Glance
Smith & Nephew plc
Croxley Park
Watford, Herefordshire WD18 8YE
| Phone | 44-1923-477-100 | Revenue | 6.16B | |
| Industry | Medical Specialties | Net Income | 625.00M | |
| Sector | Health Technology | 2025 Sales Growth | 6.093% | |
| Fiscal Year-end | 12 / 2026 | Employees | 18,362 | |
| View SEC Filings |
SNNUF Valuation
| P/E Current | 21.258 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 23.108 |
| Price to Sales Ratio | 2.359 |
| Price to Book Ratio | 2.675 |
| Price to Cash Flow Ratio | 11.32 |
| Enterprise Value to EBITDA | 10.608 |
| Enterprise Value to Sales | 2.809 |
| Total Debt to Enterprise Value | 0.192 |
SNNUF Efficiency
| Revenue/Employee | 335,693.28 |
| Income Per Employee | 34,037.687 |
| Receivables Turnover | 4.635 |
| Total Asset Turnover | 0.592 |
SNNUF Liquidity
| Current Ratio | 2.572 |
| Quick Ratio | 1.245 |
| Cash Ratio | 0.349 |
SNNUF Profitability
| Gross Margin | 66.986 |
| Operating Margin | 17.164 |
| Pretax Margin | 10.805 |
| Net Margin | 10.14 |
| Return on Assets | 6.006 |
| Return on Equity | 11.844 |
| Return on Total Capital | 7.254 |
| Return on Invested Capital | 7.358 |
SNNUF Capital Structure
| Total Debt to Total Equity | 62.904 |
| Total Debt to Total Capital | 38.614 |
| Total Debt to Total Assets | 31.816 |
| Long-Term Debt to Equity | 60.068 |
| Long-Term Debt to Total Capital | 36.873 |